NewGenIvf (NIVF) Cash & Current Investments (2022 - 2025)

NewGenIvf has disclosed Cash & Current Investments across 4 years of filings, most recently posting $793608.0 for Q4 2025.

• In Q4 2025, Cash & Current Investments fell 45.56% year-over-year to $793608.0; the TTM figure through Dec 2025 stood at $793608.0 (down 45.56% YoY), while the FY2025 annual figure was $793608.0, down 45.56% from the prior year.
• Cash & Current Investments declined to $793608.0 in Q4 2025, from $2969.3 billion in the prior quarter.
• Over the last five years, Cash & Current Investments for NIVF reached as high as $2969.3 billion in Q3 2025 and fell as low as $27556.0 in Q4 2022.
• The 4-year median for Cash & Current Investments is $1.1 million (2024), against an average of $494.9 billion.
• Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 2594.33% — and 2025, when it slumped 45.56%.
• A 4-year view of Cash & Current Investments shows it stood at $27556.0 in 2022, then jumped by 96.34% to $54104.0 in 2023, then jumped by 2594.33% to $1.5 million in 2024, then tumbled by 45.56% to $793608.0 in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $793608.0, $2969.3 billion, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.